BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12563792)

  • 1. [Studies on immunoprotection of monoclonal antibodies against Cryptosporidium parvum].
    Zong H; Li W; Zhang X; Yu S; Bai B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):101-5. PubMed ID: 12563792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro cultivation model of Cryptosporidium parvum in MDCK cells and its development].
    Chen F; Huang KH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Jun; 27(3):219-22. PubMed ID: 19852362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells.
    Gut J; Petersen C; Nelson R; Leech J
    J Protozool; 1991; 38(6):72S-73S. PubMed ID: 1818215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of new monoclonal antibodies against Cryptosporidium parvum sporozoites.
    Camero L; Arrowood M; Shulaw W; Lal AA; Xiao L
    J Eukaryot Microbiol; 1999; 46(5):58S-59S. PubMed ID: 10519248
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation and characterization of monoclonal antibodies against Cryptosporidium parvum].
    Zong H; Li W; Zhang X; Yu S
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(4):279-82. PubMed ID: 12078258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro.
    Hamer DH; Ward H; Tzipori S; Pereira ME; Alroy JP; Keusch GT
    Infect Immun; 1994 Jun; 62(6):2208-13. PubMed ID: 8188342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
    Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
    Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lectins on Cryptosporidium parvum oocyst in vitro attachment to host cells.
    Stein B; Stover L; Gillem A; Winters K; Leet JH; Chauret C
    J Parasitol; 2006 Feb; 92(1):1-9. PubMed ID: 16629306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivities with Cryptosporidium spp. by chicken monoclonal antibodies that recognize avian Eimeria spp.
    Matsubayashi M; Kimata I; Iseki M; Lillehoj HS; Matsuda H; Nakanishi T; Tani H; Sasai K; Baba E
    Vet Parasitol; 2005 Mar; 128(1-2):47-57. PubMed ID: 15725532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of semiconductor quantum dots for photostable immunofluorescence labeling of Cryptosporidium parvum.
    Lee LY; Ong SL; Hu JY; Ng WJ; Feng Y; Tan X; Wong SW
    Appl Environ Microbiol; 2004 Oct; 70(10):5732-6. PubMed ID: 15466507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in scid mice.
    Kobayashi C; Yokoyama H; Nguyen SV; Kodama Y; Kimata T; Izeki M
    Vaccine; 2004 Nov; 23(2):232-5. PubMed ID: 15531042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular like-gregarine stages of Cryptosporidium parvum.
    Rosales MJ; Cordón GP; Moreno MS; Sánchez CM
    Acta Trop; 2005 Jul; 95(1):74-8. PubMed ID: 15907779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro.
    Gut J; Nelson RG
    J Eukaryot Microbiol; 1994; 41(5):42S-43S. PubMed ID: 7528594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell response of rat liver parenchyma to the infection by the intestinal protozoan pathogen Cryptosporidium parvum (Sporozoa, Coccidia)].
    Sidorenko NV; Filimonov NIu; Anatskaia OV; Svezhova NV; Beĭer TV
    Tsitologiia; 2004; 46(2):114-24. PubMed ID: 15174350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium parvum: identification of a new surface adhesion protein on sporozoite and oocyst by screening of a phage-display cDNA library.
    Yao L; Yin J; Zhang X; Liu Q; Li J; Chen L; Zhao Y; Gong P; Liu C
    Exp Parasitol; 2007 Apr; 115(4):333-8. PubMed ID: 17097085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.
    Elliot BC; Wisnewski AV; Johnson J; Fenwick-Smith D; Wiest P; Hamer D; Kresina T; Flanigan TP
    Infect Immun; 1997 Sep; 65(9):3933-5. PubMed ID: 9284173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron microscopic observation of cytoskeletal frame structures and detection of tubulin on the apical region of Cryptosporidium parvum sporozoites.
    Matsubayashi M; Takase H; Kimata I; Nakagawa H; Tani H; Sasai K; Baba E
    Parasitology; 2008 Mar; 135(3):295-301. PubMed ID: 18039413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion.
    Flanigan TP; Wisnewski A; Wiest PM; Johnson J; Tzipori S; Hamer D; Lam N; Kresina TF
    Trans Assoc Am Physicians; 1993; 106():86-90. PubMed ID: 8036749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.